Serious risks (rare): Pancreatitis, gallbladder issues, or thyroid tumors in people with certain genetic conditions
For some patients, the consistency loss meaningfully degrades outcomes versus what a clinical session would deliver
When a drug is listed on the FDAs official drug shortage list, licensed compounding pharmacies are permitted under federal law to create compounded versions of that medication
In a Phase 2 obesity trial of retatrutide published in the New England Journal of Medicine in 2023, nausea, diarrhea, vomiting and constipation were cited as the most common adverse events, with higher doses associated with more severe problems
doi: 10.3892/mmr.2016.5414 68 BiolchiVNetoBSPiantaDBKoffWJBergerMBrumIS
choledochal cysts, pancreaticobiliary maljunction)